ASX - Delayed Quote AUD

HeraMED Limited (HMD.AX)

Compare
0.0180
+0.0010
+(5.88%)
At close: January 17 at 3:58:10 PM GMT+11
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
402.8970
402.8970
218.9150
86.6540
39.5160
Cost of Revenue
160.9600
160.9600
78.2820
42.2480
31.5830
Gross Profit
241.9370
241.9370
140.6330
44.4060
7.9330
Operating Expense
4,674.3280
4,674.3280
3,321.5150
3,983.4180
3,458.9450
Operating Income
-4,432.3910
-4,432.3910
-3,180.8820
-3,939.0120
-3,451.0120
Net Non Operating Interest Income Expense
-70.3790
-70.3790
-1,699.7810
-1,673.8930
3.1160
Other Income Expense
--
--
--
-96.0380
88.9270
Pretax Income
-4,502.7700
-4,502.7700
-4,880.6630
-5,708.9430
-3,358.9690
Net Income Common Stockholders
-4,502.7700
-4,502.7700
-4,880.6630
-5,708.9430
-3,358.9690
Basic EPS
-0.02
-0.02
-0.02
-0.03
-0.03
Diluted EPS
-0.02
-0.02
-0.02
-0.03
-0.03
Basic Average Shares
242,819.5620
266,250.3830
218,861.5280
178,499.4380
128,563.2960
Diluted Average Shares
242,819.5620
266,250.3830
218,861.5280
178,499.4380
128,563.2960
Net Income from Continuing & Discontinued Operation
-4,502.7700
-4,502.7700
-4,880.6630
-5,708.9430
-3,358.9690
Normalized Income
-4,502.7700
-4,502.7700
-4,880.6630
-5,612.9050
-3,358.9690
Interest Income
19.2580
19.2580
38.1310
0.0750
13.4410
Interest Expense
89.6370
89.6370
1,737.9120
1,673.9680
10.3250
Net Interest Income
-70.3790
-70.3790
-1,699.7810
-1,673.8930
3.1160
EBIT
-4,413.1330
-4,413.1330
-3,142.7510
-4,034.9750
-3,348.6440
EBITDA
-3,972.0620
-3,972.0620
-2,784.3390
-3,763.2750
-3,089.9700
Reconciled Cost of Revenue
160.9600
160.9600
78.2820
42.2480
31.5830
Reconciled Depreciation
441.0710
441.0710
358.4120
271.7000
258.6740
Net Income from Continuing Operation Net Minority Interest
-4,502.7700
-4,502.7700
-4,880.6630
-5,708.9430
-3,358.9690
Total Unusual Items Excluding Goodwill
--
--
--
-96.0380
--
Total Unusual Items
--
--
--
-96.0380
--
Normalized EBITDA
-3,972.0620
-3,972.0620
-2,784.3390
-3,667.2370
-3,089.9700
12/31/2020 - 12/11/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers